Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)

Novo Nordisk Investigational Site, New York

Novo Nordisk Investigational Site, Spring Valley

Novo Nordisk Investigational Site, Mineola

Novo Nordisk Investigational Site, Buffalo

Novo Nordisk Investigational Site, Pittsburgh

Novo Nordisk Investigational Site, Wilmington

Novo Nordisk Investigational Site, Tallahassee

Novo Nordisk Investigational Site, Margate

Novo Nordisk Investigational Site, Miami

Novo Nordisk Investigational Site, Louisville

Novo Nordisk Investigational Site, Columbus

Novo Nordisk Investigational Site, Cleveland

Novo Nordisk Investigational Site, Iowa City

Novo Nordisk Investigational Site, Saint Paul

Novo Nordisk Investigational Site, Wheaton

Novo Nordisk Investigational Site, St Louis

Novo Nordisk Investigational Site, Dallas

Novo Nordisk Investigational Site, Dallas

Novo Nordisk Investigational Site, Centennial

Novo Nordisk Investigational Site, Phoenix

Novo Nordisk Investigational Site, Atlanta

Novo Nordisk Investigational Site, Boston

Novo Nordisk Investigational Site, Lebanon

Novo Nordisk Investigational Site, Albany

Novo Nordisk Investigational Site, Birmingham

Novo Nordisk Investigational Site, Liverpool

Novo Nordisk Investigational Site, London

Novo Nordisk Investigational Site, Manchester